Research > ETFs > ETF / ETP Commentary > 

Perhaps Some Hope For This Marijuana ETF

The Global X Cannabis ETF (POTX) is the newest member of the marijuana ETFs universe having debuted last month. POTX came to market at a time of struggles for cannabis stocks and the related ETFs and it has scuffled since coming to market, but the clouds that have recently besieged the marijuana ETF space could be ready to part.POTX’s underlying index holds “companies involved in the legal production, growth and distribution of cannabis and industrial hemp, as well as those involved in providing financial services to the cannabis industry, pharmaceutical applications of cannabis, cannabidiol (i.e., CBD), or other related uses including but not limited to extracts, derivatives or synthetic versions,” according to Global X.POTX is higher by nearly 3% over the past week, potentially one sign that marijuana equities are ready to rebound, but fortunately for investors, there’s more to the story.“Cowen analyst Vivien Azer wrote in a note to clients Friday that as investors are resetting their expectations for Canadian pot stocks, she’s looking for any indication of incremental progress heading into third-quarter earnings,” reports Connor Smith for Barron’s.Why Throwing In This Pot MattersThe new POTX holds 24 stocks, including Aurora Cannabis (ACB), Canopy Growth (CGC) and Tilray (TLRY). That underscores the point that POTX is heavily exposed to Canadian medical marijuana purveyors. However, POTX is positioned to take advantage of increased cannabis legalization in the U.S.Good news for POTX and other Canada-heavy cannabis ETF: Canadian retail sales appear sturdy.“Retail sales have grown double digits in five of the last six months and have more than doubled during that time span,” said Azer, according to Barron’s. “This performance comes while the industry has faced multiple headwinds from novel form factor delays, widening price gaps vs. illicit market, lack of retail infrastructure, as well as an inventory glut in oil/capsules and value-based dry flower.”Related: Plenty Of Potential For The POTX Cannabis ETFThere are some inklings the political environment in the U.S. is growing increasingly favorable toward the cannabis industry and related investments, indicating the long-term growth trajectory for POTX is indeed compelling.The industries that constitute the multi-billion dollar cannabis universe represent a new frontier, where proper caution and due diligence must be exercised surrounding its regulations and risks, in seeking attractive long-term cannabis investment opportunities.This article originally appeared on ETFTrends.com

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.